ZY
Zhengye Biotechnology Holding Limited
ZYBT · NASDAQ
$1.37 -2.84% (-$0.04)
1M -29.74%
Market Cap ¥434.2M
P/E Ratio -
Div. Yield -
ROE 25.78%
Valuation
32 /100
Expensive P/S 3.73x
P/B 1.74x
P/FCF 617.70x
Growth
0 /100
Declining Rev. growth 23.53%
Book val. growth 5.55%
EPS growth N/A
Profitability
9 /100
Weak Gross margin 20.51%
Net margin 59.97%
FCF margin 0.60%
Quality
3 /100
Poor ROIC 20.63%
ROE 25.78%
Asset turnover 0.27x
Debt
57 /100
Moderate Debt/Equity 0.30x
Current ratio 1.14x
Int. coverage -20.14x
Stability
55 /100
Moderate Beta -2.53x
Rev. volatility 13.28%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ZYBT
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Songlin Song
Employees
269
Headquarters
Jilin